Investor

FT Global Pharma and Biotech Summit

Name: FT Global Pharma and Biotech Summit
Location: London, United Kingdom

This high level business summit gathers pharmaceutical executives to discuss drug development economics, biotech investing, and geopolitical risks.

When: November, Early November
Where: London, United KingdomView on Google Maps
Format: Hybrid
Organiser: Financial Times
Region: Europe
Scale: About 600 senior attendees
Founded: 2013

The Signal

Organised by the Financial Times, this summit addresses the strategic and financial forces shaping the life sciences industry. Sessions focus on drug pricing policies, geopolitical supply chain pressures, and the commercial impact of gene therapies. For investors, the event provides a macroeconomic view of life sciences capital allocation. For healthtech operators, it highlights how pharmaceutical companies are using digital tools to lower clinical trial costs.

What to expect

Drug pricing reform debates
M&A deal flow forecasts
AI drug discovery productivity metrics
Clinical trial diversity strategies

Who is in the room

Pharmaceutical chief executives, biotech founders, life science venture capitalists, investment bankers, and health policy leaders attend.

Background

The Financial Times created the summit to bring rigorous financial and geopolitical analysis to the pharmaceutical industry. It has evolved into a key European calendar event for senior life sciences executives.

Official event site